Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,910,000 | 9,672,000 | 9,454,000 | 6,252,000 | 3,476,000 |
| Depreciation Amortization | 773,000 | 3,158,000 | 2,315,000 | 1,532,000 | 755,000 |
| Income taxes - deferred | 557,000 | -836,000 | -849,000 | -504,000 | -4,000 |
| Accounts receivable | -173,000 | -883,000 | -510,000 | -609,000 | -625,000 |
| Other Working Capital | -2,618,000 | 1,523,000 | -717,000 | -1,554,000 | -2,063,000 |
| Other Operating Activity | 346,000 | 1,664,000 | 1,154,000 | 1,108,000 | 777,000 |
| Operating Cash Flow | $2,795,000 | $14,298,000 | $10,847,000 | $6,225,000 | $2,316,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -144,000 | -1,551,000 | -1,044,000 | -911,000 | -315,000 |
| Net Acquisitions | N/A | -2,797,000 | -2,469,000 | -2,049,000 | -2,049,000 |
| Purchase Of Investment | -2,398,000 | -29,882,000 | -25,444,000 | -16,820,000 | -1,036,000 |
| Sale Of Investment | 6,600,000 | 30,396,000 | 18,438,000 | 10,582,000 | 4,897,000 |
| Other Investing Activity | -2,000 | -778,000 | -331,000 | -62,000 | -57,000 |
| Investing Cash Flow | $4,056,000 | $-4,612,000 | $-10,850,000 | $-9,260,000 | $1,440,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,547,000 | 9,729,000 | 7,216,000 | 3,586,000 | 3,644,000 |
| Debt Issued | 2,000 | 4,470,000 | 4,471,000 | 4,404,000 | 8,000 |
| Debt Repayment | -30,000 | -16,000 | -12,000 | -5,000 | -3,000 |
| Common Stock Issued | 880,000 | 1,246,000 | 946,000 | 717,000 | 185,000 |
| Common Stock Repurchased | -67,000 | -2,525,000 | -1,672,000 | -929,000 | -435,000 |
| Dividend Paid | -1,565,000 | -6,156,000 | -4,601,000 | -3,043,000 | -1,480,000 |
| Other Financing Activity | -1,950,000 | -11,200,000 | -10,044,000 | -6,194,000 | -2,744,000 |
| Financing Cash Flow | $-1,183,000 | $-4,452,000 | $-3,696,000 | $-1,464,000 | $-825,000 |
| Exchange Rate Effect | 57,000 | -47,000 | -39,000 | 118,000 | 70,000 |
| Beginning Cash Position | 24,542,000 | 19,355,000 | 19,355,000 | 19,355,000 | 19,355,000 |
| End Cash Position | 30,267,000 | 24,542,000 | 15,617,000 | 14,974,000 | 22,356,000 |
| Net Cash Flow | $5,725,000 | $5,187,000 | $-3,738,000 | $-4,381,000 | $3,001,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,795,000 | 14,298,000 | 10,847,000 | 6,225,000 | 2,316,000 |
| Capital Expenditure | -502,000 | -2,893,000 | -1,765,000 | -1,054,000 | -436,000 |
| Free Cash Flow | 2,293,000 | 11,405,000 | 9,082,000 | 5,171,000 | 1,880,000 |